Materials and Methods
Optical rotations were recorded on a Perkin-Elmer 243B digital polarimeter. NMR spectra were recorded on Inova 500 MHz NMR spectrometers. HR-ESI-MS spectra were measured on a Bruker APEX IV FTMS mass spectrometer in positive-ion mode. GC were measured on an Agilent 6890N instrument [HP-5 capillary column (28 m  0.32 mm i.d.); detection, FID; detector temperature, 260 C; column temperature, 180 C; carrier gas, N 2 ; flow rate, 40 mL/min)]. All solvents used were of analytical grade (Beijing Chemical and Industry Factory).
Silica gel (200300 mesh; Qingdao Mar. Chem. Ind. Co. Ltd.), Sephadex LH-20 gel (Pharmacia), and C 18 reverse-phased silica gel (150200 mesh; Merck, performed by applying an N 2 pressure of 0.12 Mpa) were used for column chromatography. Bis-(p-nitrophenyl) phosphate (Sigma N-3002), L-cysteine (Tianjin BODI Chemical Co. Ltd.), and EDTA (Sigma, purity is above 98 %) were used for the bioactivity assay.
The stems of S. chinensis were collected in December 2004 from Guangxi Province, P. R. 
Extraction and isolation
The dried stems (57.8 kg) of S. chinensis were extracted 2 times with 80% EtOH (2  200 L).
After evaporation of the solvent, the soluble fraction was suspended in H 2 O and extracted successively with petroleum ether (PE, 4  5 L), EtOAc (4  5 L), and n-BuOH (3  5 L).
The EtOAc extract (248 g) was subjected to column chromatography on silica gel (100200 m, 15  100 cm, 1.5 kg) and eluted with a gradient of PEMe 2 CO (5:1, 2:1, 1:1, and 1:5, each 8 L) to give fractions 110. Fraction 2 (2 g) was subjected to silica gel column chromatography (200300 m, 5  40 cm) and eluted with PEMe 2 CO (5:1, 2 L) to give 10 as colorless needles (22 mg).
Fraction 3 (40 g) was subjected to silica gel column chromatography (100200 m, 10  80 cm) and eluted with CHCl 3 MeOH (15:1, 10 L) to give 7 fractions (Frs. 3.13.7). Fraction 3.3 (3 g) was subjected to silica gel column chromatography (200300 m, 5  40 cm) and eluted with n-hexaneMe 2 CO (5:1, 3 L) to obtain 12 (14 mg). Fraction 3.4 (3 g) was subjected to silica gel column chromatography (200300 m, 5  40 cm) with elution of n-hexaneMe 2 CO (3:1, 3 L) to yield 11 (32 mg). Fraction 3.5 (4 g) was subjected to silica gel column chromatography (200300 m, 5  50 cm) and eluted with n-hexaneMe 2 CO (4:1, 3 L) to get 13 (26 mg). Compounds 14 (6 mg), 15 (11 mg), and 4 (5 mg) were obtained from Fr.
3.7 (1.2 g) by column chromatography on silica gel (200300 m, 4  40 cm) and eluted with CHCl 3 Me 2 CO (5:1, 1.5 L).
Fraction 4 (6 g) was subjected to silica gel (100200 m, 5  60 cm) column chromatography and eluted with a gradient of CHCl 3 MeOH (100:1, 20:1, 10:1, 3:1, and 1:1, each 500 mL) to give 7 fractions (Frs. 4.14.7). Fr. 4.5 (1.2 g) was subjected to silica gel column chromatography (200300 m, 3  40 cm) and eluted with CHCl 3 EtOAc (1:1, 1 L) to obtain 1 (149 mg). Fr. 4.6 (1.4 g) was subjected to LH-20 size exclusion chromatography with CHCl 3 MeOH (1:1) elution (1 mL/min) to give 7 (23 mg). Fr. 4.7 (1.9 g) was chromatographed by silica gel (200300 m, 4  40 cm) with n-hexaneEtOAc (1:1, 1.5 L) to provide 5 (13 mg).
Fraction 5 (17 g) was chromatographed by silica gel (100200 m, 6  60 cm) with a gradient of CHCl 3 MeOH (30:15:1, 5 L) to give seven fractions (Frs. 5.15.7). Fr. 5.3 (2.3 g) was subjected to silica gel column chromatography (200300 m, 4  40 cm) and eluted with CHCl 3 Me 2 CO (25:1, 10:1, 3:1, and 1:1, each 500 mL) to give three fractions (Frs. 5.3.15.3.3). Fr. 5.3.2 was applied to semi-preparative HPLC with 40% MeOH/0.1% TFA-H 2 O (2.5 mL/min) to yield 3 (11 mg, t R = 86 min) and 8 (22 mg, t R = 92 min). Fr. 5.4 (2.1 g) was subjected to silica gel column chromatography (200300 m, 4  40 cm) and eluted by CHCl 3 MeOHHCOOH (10:1:0.02, 2 L) to give 8 (210 mg) and 9 (15 mg).
Fraction 6 (37.5 g) was chromatographed by silica gel (100200 m, 10  60 cm) and eluted 4 with CHCl 3 MeOHH 2 O (lower layer, 5:1:1, 10 L）to obtain four fractions (Frs. 6.16.4). Frs. 6.1 (10.1 g) and 6.2 (2.7 g) were recrystaled respectively in EtOAc to yield 19 (2.6 g) and 6
(199 mg). Fr. 6.3 (2.3 g) was subjected to silica gel column chromatography (200300 m, 3  40 cm) with n-hexaneethyl formate (1:5, 1.2 L) to give 2 (16 mg). Fr. 6.4 (3.8 g) was subjected to LH-20 with MeOH (1 mL/min) to obtain 16 (11 mg).
The n-BuOH extract (1.5 kg) was subjected to column chromatography on HPD 100 (15  100 cm) and eluted successively with H 2 O, 20% EtOH, 40% EtOH, and 95% EtOH. The 20% EtOH residue (93.1 g, dryness) was subjected to silica gel column chromatography (100200 m, 10  100 cm) with a gradient of CHCl 3 MeOH (8:1, 4:1 and 2:1, each 5 L) to obtain seven fractions (Fr. B1B7). Fr. B2 (20 g) was subjected to Sephadex LH-20 column chromatography with 70% MeOH (2 mL/min) to give 17 (21 mg) and 18 (16 mg).
Bioactivity assay
The bioactivity assay was carried out with 33 mM TrisHCl buffer, pH 8.8, with 0.00035 U/well final concentration using a microtiter plate assay and 0.33 mM bis- (p-nitrophenyl) phosphate as substrate. L-Cysteine and EDTA were used as positive controls (with inhibitory rates of 5.65% and 72.4% at 5 M, respectively). After 30 min pre-incubation of the enzyme with the test samples (all with its purity >95%), enzyme activity was monitored spectrophotometrically at 37 C on a microtiter plate reader (Bio-Rad model 680) by following the rate (change in OD/min) of release of p-nitrophenol from p-nitrophenyl phosphate at 405 nm. All assays were conducted in triplicate. 
Fig. 2S
1 H-NMR spectrum of compound 1 (acetone-d 6 , 500 MHz).
Fig. 3S
13 C-NMR spectrum of compound 1 (acetone-d 6 , 125 MHz). 
Fig. 5S
1 H-NMR spectrum of compound 2 (acetone-d 6 , 500 MHz).
Fig. 6S
13 C-NMR spectrum of compound 3 (acetone-d 6 , 500 MHz). 
Fig. 8S
1 H-NMR spectrum of compound 3 (CD 3 OD, 500 MHz). 
Fig. 10S
13 C-NMR spectrum of compound 3 (CD 3 OD, 500 MHz).
Fig. 11S
HR-ESI-MS spectrum of compound 3.
Fig. 12S
1 H-NMR spectrum of compound 4 (acetone-d 6 , 500 MHz). 
